T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAX
201
DELISTED
Rackspace Hosting Inc
RAX
| $587M | 0.12% |
11,378,117
+3,108,590
| +38% | +$153M |
|
202
Berkshire Hathaway Class B
BRK.B
$1.09T
| $583M | 0.12% |
4,036,847
-31,857
| -0.8% | -$4.69M |
|
203
NRG Energy
NRG
$25.4B
| $582M | 0.12% |
23,111,891
-11,392,224
| -33% | -$288M |
|
204
BorgWarner
BWA
$14B
| $581M | 0.12% |
10,904,879
+10,480,447
| +2,469% | +$534M |
|
205
Emerson Electric
EMR
$91.4B
| $580M | 0.12% |
10,243,003
-932,550
| -8% | -$54.2M |
|
|
XL
206
DELISTED
XL Group Ltd.
XL
| $580M | 0.12% |
15,758,924
+160,435
| +1% | +$5.75M |
|
|
KSU
207
DELISTED
Kansas City Southern
KSU
| $580M | 0.12% |
5,680,395
-5,844,418
| -51% | -$662M |
|
208
Gartner
IT
$11.3B
| $578M | 0.12% |
6,899,124
-1,140,186
| -14% | -$94.1M |
|
|
APC
209
DELISTED
Anadarko Petroleum
APC
| $570M | 0.12% |
6,877,484
-1,092,790
| -14% | -$89.4M |
|
|
RDS.B
210
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $567M | 0.12% |
9,035,742
+118,555
| +1% | +$7.84M |
|
211
Blackrock
BLK
$180B
| $565M | 0.12% |
1,545,673
-74,534
| -5% | -$27M |
|
|
VIAB
212
DELISTED
Viacom Inc. Class B
VIAB
| $556M | 0.11% |
8,147,868
+615,452
| +8% | +$42.5M |
|
213
Choice Hotels
CHH
$4.75B
| $553M | 0.11% |
8,629,463
+100,170
| +1% | +$6.1M |
|
214
Teleflex
TFX
$6.03B
| $552M | 0.11% |
4,571,810
+142,630
| +3% | +$16.5M |
|
|
CTLT
215
DELISTED
CATALENT, INC.
CTLT
| $551M | 0.11% |
17,690,798
+7,626,614
| +76% | +$220M |
|
216
Walmart Inc
WMT
$923B
| $550M | 0.11% |
20,067,606
-1,351,308
| -6% | -$38.3M |
|
217
Dentsply Sirona
XRAY
$2.27B
| $548M | 0.11% |
10,773,706
-3,533,446
| -25% | -$182M |
|
|
TWC
218
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $543M | 0.11% |
3,623,234
+242,741
| +7% | +$36.2M |
|
|
SIRO
219
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $533M | 0.11% |
5,925,726
-83,511
| -1% | -$7.54M |
|
|
ACT.PRA
220
DELISTED
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
| $532M | 0.11% |
+516,600
| New | +$540M |
|
221
General Motors
GM
$76.1B
| $529M | 0.11% |
14,100,858
+81,920
| +0.6% | +$2.98M |
|
222
Sprouts Farmers Market
SFM
$8.03B
| $523M | 0.11% |
14,849,866
+975,897
| +7% | +$34.6M |
|
223
Cboe Global Markets
CBOE
$30.4B
| $523M | 0.11% |
9,110,787
+689,910
| +8% | +$43M |
|
|
CA
224
DELISTED
CA, Inc.
CA
| $518M | 0.11% |
15,894,149
+5,646,874
| +55% | +$179M |
|
225
Jones Lang LaSalle
JLL
$16.7B
| $514M | 0.11% |
3,019,120
+24,630
| +0.8% | +$3.89M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.